Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

James Suen

Concepts (310)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
74
1.470
Why?
Head and Neck Neoplasms
14
2012
289
1.230
Why?
Carcinoma, Squamous Cell
12
2011
331
0.840
Why?
Neck
7
2018
97
0.680
Why?
Vascular Malformations
3
2010
105
0.630
Why?
Head
5
2018
70
0.590
Why?
Patients
1
2018
50
0.550
Why?
Terminal Care
1
2018
37
0.550
Why?
Hemangioma
3
2018
86
0.520
Why?
Attitude to Health
1
2018
191
0.510
Why?
Laryngectomy
3
2013
27
0.510
Why?
Laryngeal Neoplasms
2
2007
43
0.480
Why?
Carcinoma, Merkel Cell
4
2016
41
0.440
Why?
Quality of Life
3
2012
893
0.440
Why?
Laser Therapy
3
2011
74
0.440
Why?
Laryngeal Diseases
1
2013
11
0.390
Why?
Nuclear Proteins
6
2015
247
0.390
Why?
Herpes Simplex
1
2013
25
0.390
Why?
Parotid Diseases
1
2012
3
0.390
Why?
Neuromuscular Agents
1
2012
8
0.390
Why?
Botulinum Toxins, Type A
1
2012
14
0.380
Why?
Leukoplakia, Oral
1
2011
6
0.370
Why?
Aminolevulinic Acid
1
2011
9
0.370
Why?
Lasers, Dye
1
2011
10
0.360
Why?
Eating
1
2012
158
0.360
Why?
Photosensitizing Agents
1
2011
20
0.360
Why?
Photochemotherapy
1
2011
32
0.350
Why?
Survivors
1
2012
121
0.350
Why?
Flow Cytometry
6
2019
396
0.350
Why?
Neoplastic Cells, Circulating
4
2019
34
0.340
Why?
Humans
48
2019
52441
0.330
Why?
Female
29
2018
28277
0.330
Why?
Cheek
1
2010
9
0.320
Why?
Lip
1
2010
11
0.320
Why?
Pain
1
2012
373
0.320
Why?
Facial Neoplasms
1
2010
22
0.320
Why?
Male
29
2018
26874
0.310
Why?
Middle Aged
20
2018
13133
0.310
Why?
Receptors, Progesterone
1
2009
68
0.310
Why?
Lymphatic Vessels
1
2009
38
0.300
Why?
Aged
16
2018
10242
0.300
Why?
Postoperative Complications
3
2012
1065
0.300
Why?
Skin Neoplasms
4
2016
496
0.290
Why?
Adult
20
2017
14205
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1020
0.280
Why?
Surgical Flaps
1
2009
111
0.280
Why?
Neoplasms
1
2018
1314
0.280
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.280
Why?
Laryngeal Nerves
1
2007
15
0.280
Why?
Melanoma
2
2022
272
0.270
Why?
Factor VII
1
2007
3
0.270
Why?
Intracranial Arteriovenous Malformations
1
2007
31
0.260
Why?
Dilatation
2
2017
27
0.250
Why?
Gene Silencing
4
2009
122
0.220
Why?
Disease Models, Animal
3
2016
1483
0.220
Why?
Adolescent
10
2012
6713
0.200
Why?
Cell Proliferation
4
2016
1013
0.200
Why?
Melanoma, Experimental
2
2016
34
0.200
Why?
Immunohistochemistry
8
2014
977
0.190
Why?
Retrospective Studies
10
2015
6694
0.190
Why?
Treatment Outcome
7
2018
5508
0.190
Why?
Promoter Regions, Genetic
7
2015
465
0.190
Why?
Muscarinic Agonists
1
2002
10
0.190
Why?
Xerostomia
1
2002
4
0.190
Why?
Sjogren's Syndrome
1
2002
14
0.190
Why?
Endoscopy
2
2015
126
0.190
Why?
Plasmodium yoelii
1
2022
12
0.190
Why?
Thiophenes
1
2002
45
0.190
Why?
Nitric Oxide Synthase Type III
2
2013
83
0.180
Why?
Quinuclidines
1
2002
39
0.180
Why?
Malaria
1
2022
35
0.180
Why?
Transcription Factors
2
2015
570
0.180
Why?
Veins
3
2010
74
0.170
Why?
Embolization, Therapeutic
3
2011
93
0.170
Why?
Azepines
3
2016
21
0.170
Why?
Triazoles
3
2016
115
0.160
Why?
Child
10
2012
7194
0.160
Why?
Neoplasm Invasiveness
3
2010
278
0.150
Why?
Child, Preschool
8
2012
4046
0.150
Why?
Mast Cells
1
2018
55
0.140
Why?
Mice
10
2022
5899
0.140
Why?
Combined Modality Therapy
4
2018
641
0.140
Why?
Ki-67 Antigen
3
2013
57
0.140
Why?
Cricoid Cartilage
1
2017
10
0.140
Why?
Estradiol
1
2018
226
0.130
Why?
Mice, Nude
5
2016
230
0.130
Why?
Trachea
1
2017
55
0.130
Why?
Follow-Up Studies
3
2011
2294
0.130
Why?
Biopsy
3
2015
594
0.130
Why?
Lasers, Semiconductor
2
2022
7
0.130
Why?
Infant
7
2018
3709
0.130
Why?
Embolism
1
2016
18
0.120
Why?
Photoacoustic Techniques
1
2016
22
0.120
Why?
Neoplasm Staging
2
2010
768
0.120
Why?
Benzoxazoles
1
2016
12
0.120
Why?
Matrix Metalloproteinase 2
1
2016
59
0.120
Why?
Matrix Metalloproteinase 9
1
2016
88
0.120
Why?
Qualitative Research
1
2018
365
0.120
Why?
Tracheotomy
1
2015
15
0.120
Why?
TOR Serine-Threonine Kinases
1
2016
83
0.120
Why?
Tracheal Stenosis
1
2015
13
0.120
Why?
Laryngostenosis
1
2015
11
0.120
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
Why?
Aged, 80 and over
6
2015
3449
0.120
Why?
Larynx
2
2017
30
0.110
Why?
Pyrimidines
1
2016
199
0.110
Why?
Proto-Oncogene Proteins c-myc
1
2014
53
0.110
Why?
Disease Progression
3
2014
870
0.110
Why?
Fluorouracil
2
2004
56
0.110
Why?
Gene Expression Regulation, Neoplastic
3
2015
853
0.110
Why?
Carcinoma
2
2012
135
0.110
Why?
DNA Methylation
5
2009
573
0.110
Why?
Breast Neoplasms
2
2015
1203
0.100
Why?
Apoptosis
2
2016
1120
0.100
Why?
Animals
10
2022
13485
0.100
Why?
Mastication
1
2012
5
0.100
Why?
Trismus
1
2012
2
0.100
Why?
DNA, Neoplasm
2
2011
146
0.100
Why?
Cisplatin
2
2004
282
0.090
Why?
Adaptor Proteins, Signal Transducing
3
2009
202
0.090
Why?
Radiotherapy, Adjuvant
1
2012
65
0.090
Why?
Receptors, Cell Surface
1
2013
111
0.090
Why?
Recurrence
2
2011
680
0.090
Why?
Lymphangioma, Cystic
1
2011
9
0.090
Why?
Endothelium, Lymphatic
1
2011
8
0.090
Why?
Chemoradiotherapy
1
2012
50
0.090
Why?
Antigens, CD
1
2013
213
0.090
Why?
Syndrome
1
2012
247
0.090
Why?
Administration, Topical
1
2011
62
0.090
Why?
Epigenesis, Genetic
1
2015
396
0.090
Why?
Lymphatic Abnormalities
1
2011
20
0.090
Why?
Propranolol
1
2012
76
0.090
Why?
Microtubule-Associated Proteins
1
2011
61
0.090
Why?
Immunoenzyme Techniques
4
2016
134
0.090
Why?
Enteral Nutrition
1
2012
154
0.090
Why?
Deglutition Disorders
1
2012
76
0.090
Why?
Homeodomain Proteins
1
2011
80
0.090
Why?
Diagnosis, Differential
2
2011
1028
0.090
Why?
Weight Gain
1
2012
235
0.090
Why?
Tumor Suppressor Proteins
1
2011
127
0.090
Why?
Brain Neoplasms
1
2014
302
0.080
Why?
Risk Assessment
1
2015
1349
0.080
Why?
Xenograft Model Antitumor Assays
3
2016
218
0.080
Why?
Epigenomics
1
2011
75
0.080
Why?
Diagnostic Imaging
1
2011
171
0.080
Why?
Neoplasm Proteins
2
2003
328
0.080
Why?
Neoplastic Stem Cells
1
2011
88
0.080
Why?
Lip Neoplasms
1
2010
3
0.080
Why?
Neoplasm Recurrence, Local
2
2019
639
0.080
Why?
Hospitals, Teaching
1
2010
52
0.080
Why?
Neoadjuvant Therapy
1
2011
124
0.080
Why?
Lasers, Solid-State
1
2010
30
0.080
Why?
Survival Rate
3
2011
944
0.080
Why?
Medical Records
1
2010
83
0.080
Why?
Microsatellite Instability
1
2009
21
0.080
Why?
Vascular Surgical Procedures
1
2011
166
0.080
Why?
Melanins
1
2009
20
0.080
Why?
Mouth
1
2010
33
0.080
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
Why?
Carcinoma, Medullary
1
2009
12
0.080
Why?
Pilot Projects
1
2011
725
0.080
Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.070
Why?
Immunotherapy
1
2011
251
0.070
Why?
Receptors, Estrogen
1
2009
133
0.070
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
24
0.070
Why?
Port-Wine Stain
1
2008
14
0.070
Why?
Muscle, Smooth, Vascular
1
2009
135
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1365
0.070
Why?
Blotting, Western
3
2016
587
0.070
Why?
Thyroid Neoplasms
1
2009
111
0.070
Why?
Vascular Endothelial Growth Factor A
1
2008
186
0.070
Why?
Cytokines
1
2011
622
0.070
Why?
Early Detection of Cancer
2
2022
185
0.070
Why?
Tumor Cells, Cultured
3
2016
441
0.070
Why?
Factor VIIa
1
2007
8
0.070
Why?
Jaw Diseases
1
2007
6
0.070
Why?
Practice Guidelines as Topic
1
2010
498
0.070
Why?
Infant, Newborn
2
2011
2871
0.070
Why?
Practice Management, Medical
1
2006
9
0.060
Why?
Osteonecrosis
1
2007
35
0.060
Why?
Postoperative Hemorrhage
1
2007
54
0.060
Why?
Tongue
1
2007
41
0.060
Why?
Bone Density Conservation Agents
1
2007
75
0.060
Why?
Cell Line, Tumor
3
2015
1429
0.060
Why?
Diphosphonates
1
2007
92
0.060
Why?
Otolaryngology
1
2006
62
0.060
Why?
Recombinant Proteins
1
2007
490
0.060
Why?
Prospective Studies
1
2011
2433
0.060
Why?
Skin
1
2008
416
0.060
Why?
Mice, Inbred NOD
2
2016
91
0.060
Why?
Mice, SCID
2
2016
178
0.060
Why?
Neoplasm Metastasis
2
2015
235
0.060
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.050
Why?
DNA Repair Enzymes
1
2004
42
0.050
Why?
Ataxia Telangiectasia
1
2004
6
0.050
Why?
Cross-Sectional Studies
2
2012
1677
0.050
Why?
Statistics, Nonparametric
1
2004
199
0.050
Why?
Polymerase Chain Reaction
4
2009
458
0.050
Why?
Genes, p16
1
2003
9
0.050
Why?
Lymph Node Excision
1
2004
133
0.050
Why?
Radiotherapy
1
2004
128
0.050
Why?
Magnetic Resonance Angiography
2
2018
67
0.050
Why?
Magnetic Resonance Imaging
2
2007
1507
0.050
Why?
Proteoglycans
1
2003
86
0.050
Why?
Young Adult
2
2012
4346
0.050
Why?
Antigens, Nuclear
2
2013
24
0.050
Why?
Transplantation, Heterologous
2
2013
78
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
580
0.050
Why?
Plasmodium falciparum
1
2022
23
0.050
Why?
Erythrocytes
1
2022
68
0.050
Why?
Membrane Glycoproteins
1
2003
239
0.050
Why?
Double-Blind Method
1
2002
726
0.040
Why?
Survival Analysis
3
2009
656
0.040
Why?
Tryptases
1
2018
4
0.040
Why?
Arkansas
1
2004
2013
0.040
Why?
Estrogen Receptor beta
1
2018
54
0.040
Why?
Estrogen Receptor alpha
1
2018
86
0.040
Why?
Protein Transport
1
2018
172
0.040
Why?
Ultrasonography, Doppler
1
2018
42
0.030
Why?
Biopsy, Fine-Needle
2
2009
104
0.030
Why?
Cadaver
1
2017
88
0.030
Why?
Pressure
1
2017
100
0.030
Why?
Molecular Imaging
1
2016
28
0.030
Why?
Serum
1
2016
32
0.030
Why?
Risk Factors
3
2015
3971
0.030
Why?
Drug Synergism
1
2016
147
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
18
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
182
0.030
Why?
Acetylation
1
2015
96
0.030
Why?
Enhancer Elements, Genetic
1
2015
60
0.030
Why?
Keratin-20
1
2014
7
0.030
Why?
Mammography
1
2015
97
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2014
18
0.030
Why?
Drug Therapy, Combination
1
2016
404
0.030
Why?
Prognosis
3
2004
2100
0.030
Why?
Chromatin
1
2015
143
0.030
Why?
Cell Cycle Proteins
1
2015
168
0.030
Why?
HEK293 Cells
1
2014
236
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
38
0.030
Why?
Gene Expression Regulation
1
2018
1004
0.030
Why?
Comorbidity
1
2015
637
0.030
Why?
Protein Binding
1
2015
673
0.030
Why?
Down-Regulation
1
2014
348
0.030
Why?
Actins
1
2013
112
0.020
Why?
RNA, Messenger
1
2016
1134
0.020
Why?
Base Sequence
2
2004
632
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Predictive Value of Tests
1
2014
938
0.020
Why?
Cell Line
1
2014
1020
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
46
0.020
Why?
Tissue Culture Techniques
1
2011
42
0.020
Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
Why?
Gluconates
1
2011
1
0.020
Why?
Graft Survival
1
2011
157
0.020
Why?
Indomethacin
1
2011
36
0.020
Why?
Gene Expression Profiling
1
2016
1099
0.020
Why?
Injections, Subcutaneous
1
2011
54
0.020
Why?
Interleukin-2
1
2011
69
0.020
Why?
Carrier Proteins
2
2003
312
0.020
Why?
Time Factors
2
2007
2987
0.020
Why?
Interleukin-1beta
1
2011
84
0.020
Why?
Interferon-gamma
1
2011
169
0.020
Why?
Cyclophosphamide
1
2011
176
0.020
Why?
Drug Administration Schedule
1
2011
370
0.020
Why?
Disease-Free Survival
1
2011
461
0.020
Why?
Glottis
1
2010
34
0.020
Why?
Endothelial Cells
1
2011
283
0.020
Why?
Sclerotherapy
1
2010
47
0.020
Why?
Calcitonin
1
2009
30
0.020
Why?
Tumor Necrosis Factor-alpha
1
2011
390
0.020
Why?
Thyroidectomy
1
2009
61
0.020
Why?
Paraffin Embedding
1
2008
52
0.020
Why?
Mice, Transgenic
1
2009
566
0.020
Why?
Signal Transduction
1
2014
1724
0.020
Why?
Curettage
1
2007
13
0.020
Why?
Dental Care
1
2007
11
0.020
Why?
Mouth Floor
1
2007
5
0.020
Why?
Polyvinyl Alcohol
1
2007
10
0.020
Why?
Hyperbaric Oxygenation
1
2007
15
0.020
Why?
Collateral Circulation
1
2007
38
0.020
Why?
Pharyngeal Diseases
1
2007
12
0.020
Why?
Current Procedural Terminology
1
2006
10
0.020
Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
Why?
Cutaneous Fistula
1
2007
14
0.020
Why?
Neck Dissection
1
2007
29
0.020
Why?
Angiography
1
2007
111
0.020
Why?
Office Visits
1
2006
45
0.020
Why?
Fistula
1
2007
25
0.020
Why?
Salvage Therapy
1
2007
137
0.020
Why?
Imidazoles
1
2007
114
0.020
Why?
Genetic Predisposition to Disease
1
2009
525
0.020
Why?
Adrenal Cortex Hormones
1
2007
116
0.020
Why?
Preoperative Care
1
2007
173
0.010
Why?
Ultrasonography
1
2006
416
0.010
Why?
United States
1
2015
5215
0.010
Why?
Guanine
1
2004
39
0.010
Why?
DNA Adducts
1
2004
79
0.010
Why?
Methylation
1
2004
124
0.010
Why?
Syndecans
1
2003
37
0.010
Why?
Syndecan-1
1
2003
73
0.010
Why?
Base Pair Mismatch
1
2003
21
0.010
Why?
Cell Count
1
2003
143
0.010
Why?
Antineoplastic Agents
1
2011
1216
0.010
Why?
Alcohol Drinking
1
2003
235
0.010
Why?
DNA Repair
1
2003
194
0.010
Why?
Molecular Sequence Data
1
2003
778
0.010
Why?
Anti-Bacterial Agents
1
2007
816
0.010
Why?
Smoking
1
2003
514
0.010
Why?
Multiple Myeloma
1
2007
3013
0.010
Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description